
Caregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.
The worried parents of a health 10-year-old girl ask you to evaluate her for a total-body red rash associated with scaling and edema.






